BACKGROUND: It has been proposed that correction of offspring weight percentiles (customization) might improve the prediction of adverse pregnancy outcome; however, the approach is not accepted universally. A complication in the interpretation of the data is that the main method for calculation of customized percentiles uses a fetal growth standard, and multiple analyses have compared the results with birthweight-based standards. OBJECTIVES: First, we aimed to determine whether women who deliver small-for-gestational-age infants using a customized standard differed from other women. Second, we aimed to compare the association between birthweight percentile and adverse outcome using 3 different methods for percentile calculation: (1) a noncustomized actual birthweight standard, (2) a noncustomized fetal growth standard, and (3) a fully customized fetal growth standard. STUDY DESIGN: We analyzed data from the Pregnancy Outcome Prediction study, a prospective cohort study of nulliparous women who delivered in Cambridge, UK, between 2008 and 2013. We used a composite adverse outcome, namely, perinatal morbidity or preeclampsia. Receiver operating characteristic curve analysis was used to compare the 3 methods of calculating birthweight percentiles in relation to the composite adverse outcome. RESULTS: We confirmed previous observations that delivering an infant who was small for gestational age (<10th percentile) with the use of a fully customized fetal growth standard but who was appropriate for gestational age with the use of a noncustomized actual birthweight standard was associated with higher rates of adverse outcomes.
However, we also observed that the mothers of these infants were 3e4 times more likely to be obese and to deliver preterm. When we compared the risk of adverse outcome from logistic regression models that were fitted to the birthweight percentiles that were derived by each of the 3 predefined methods, the areas under the receiver operating characteristic curves were similar for all 3 methods: 0.56 (95% confidence interval, 0.54e0.59) fully customized, 0.56 (95% confidence interval, 0.53e0.59) noncustomized fetal weight standard, and 0.55 (95% confidence interval, 0.53e0.58) noncustomized actual birthweight standard. When we classified the top 5% of predicted risk as high risk, the methods that used a fetal growth standard showed attenuation after adjustment for gestational age, whereas the birthweight standard did not. Further adjustment for the maternal characteristics, which included weight, attenuated the association with the customized standard, but not the other 2 methods. The associations after full adjustment were similar when we compared the 3 approaches. CONCLUSION: The independent association between birthweight percentile and adverse outcome was similar when we compared actual birthweight standards and fetal growth standards and compared customized and noncustomized standards. Use of fetal weight standards and customized percentiles for maternal characteristics could lead to stronger associations with adverse outcome through confounding by preterm birth and maternal obesity.
Key words: adverse perinatal outcome, birthweight, customization, fetal growth, small for gestational age A bnormal birthweight is one of the major associations with adverse pregnancy outcome. Small-forgestational-age (SGA) birthweight is sometimes caused by fetal growth restriction that is associated with an increased risk of preeclampsia and perinatal morbidity and death. 1 Largefor-gestational-age (LGA) birthweight is sometimes caused by excessive fetal growth that is associated with maternal obesity and/or diabetes mellitus and can also result in perinatal morbidity and death. 2 Understanding the causes, nature, and strength of these associations is important because assessment of abnormal fetal growth with the use of ultrasound scanning is one of the key methods for the identification of pregnancies that are at increased risk of complications. Multiple other factors determine the size of the fetus, most obviously the gestational age and fetal sex. However, there is still a great deal of variability in fetal size, which is not explained by these factors. Hence, the populations of SGA and LGA fetuses and infants contain large numbers of healthy pregnancies; a key challenge in assessment of these associations and exploiting them for clinical risk assessment is differentiation between healthy and pathologic pregnancies in which the fetus is either SGA or LGA. One approach to this task is to adjust the estimate of the birthweight percentile for the maternal characteristics that are associated with birthweight, such as parity, ethnicity, bodyweight, and height. 3 The appropriateness of this is debated because it is unclear whether some of these features are truly physiologic determinants of growth or whether growth lies on the causal pathway between the maternal characteristic and adverse outcome. 4 For example, nulliparity is associated with reduced fetal growth and is also associated with an increased risk of stillbirth and preeclampsia. 5 Adjustment of birthweight A further complexity is how to assess the size of the fetus at preterm gestational ages. Studies have shown that slowing of fetal growth in the second trimester is a risk factor for spontaneous preterm birth. 6, 7 It follows that the distribution of actual birthweights at a given week of gestational age preterm may be shifted towards lower values when compared with on-going pregnancies. A study of fetal weight and birthweight percentiles from the InterGrowth21 study demonstrated that, at 28 weeks gestation, the 50th percentile of birthweight was actually <3rd percentile of estimated fetal weight. 8 These observations suggest that assessment of birthweight at preterm gestational ages should be performed with the use of a fetal growth standard. However, a consequence of this will be that a much larger proportion of preterm infants will be classified as SGA. This will complicate comparisons of birthweight standards because, by far, the strongest risk factor for perinatal morbidity and death is preterm birth.
The aim of the present study was to compare the associations between birthweight percentile calculated with the use of a noncustomized standard based on observed birthweights at a given week of gestation with percentiles that are calculated with the use of a fetal growth standard, with and without customization for maternal characteristics.
Methods

Study design and data collection
The Pregnancy Outcome Prediction study was a prospective cohort study that has been described previously in detail. 9 In brief, nulliparous women who attended the Rosie Hospital for their dating ultrasound scan between January 14, 2008 
Exclusions
Records with missing data on birthweight, gestational age, fetal sex, or birth outcome and all records in which data on any of the variables that were used for customization (maternal weight, height or ethnicity) were missing were excluded. Miscarriages, terminations of pregnancy, and antepartum stillbirths were also excluded because of the complexities in categorization of birthweight because of maceration after intrauterine fetal death.
Exposures and outcomes
Customized birthweight percentiles (corrected for parity, height, weight, ethnicity, gestational age at birth, and fetal sex) were obtained from the latest model of Gestation-Related Optimal Weight (GROW; version 6.7.8.1; Perinatal Institute, Birmingham, UK) with the use of a bulk percentile calculator (Perinatal Institute). 10 Partial customization was performed with the same fetal weight standard 11 and centile calculator but correcting only for gestational age at birth and fetal sex (we call these population percentiles using fetal weight standard). Population-based birthweight percentiles were calculated from a UK 1990 reference with the use of the zanthro package (Stata Corporation, College Station, TX) and correction for gestational age at birth and fetal sex; the actual birthweight standard was used in these calculations. 12 Exposures SGA was defined as birthweight <10th percentile. To understand how maternal and obstetric characteristics might have varied in previous analyses, we described the cohort using 4 groups: (1) not SGA, (2) SGA with the use of customized but not population percentile, (3) SGA with the use of population but not customized percentile, and (4) SGA with the use of both customized and population percentile. Any differences in the analyses may be attributed to either customization or different reference standard. To compare the different methods, 3 different percentiles were compared: (1) a birthweight standard, 12 (2) a sex and gestational age corrected fetal weight standard, 11 and (3) Original Research OBSTETRICS ajog.org between birthweight percentile and the outcome was nonlinear, the best-fitting degree-2 fractional polynomial model was chosen to represent this association. Fractional powers were chosen from the set (e2, e1, e0.5, 0, 0.5, 1, 2, 3). This was repeated for all 3 birthweight percentiles. The predicted risk of outcome was calculated from the fractional polynomial model with the use of Stata postestimation command epredicte with option pr, and the e centilee command with option c(90,95) were used to obtain the top 10% and top 5% risk cut-offs, respectively. The predicted risk was analyzed as a continuous variable, receiver operating characteristic (ROC) curves were estimated, and the areas under the ROC curves were compared. Logistic regression models were then fitted between high predicted risk (top 5% or top 10%) and the composite adverse outcome with and without adjustment for gestational age and other characteristics used in customization. Odds ratios (OR) and 95% confidence intervals (CI) were estimated. The association between maternal characteristics and fetal weight at 36 weeks and birthweight was modeled with the use of linear regression; adjusted r 2 was calculated to estimate the variance in weight explained by the maternal characteristics.
Results
In total, 4095 women were included in the analysis. In Table 1 , we present the characteristics of the cohort in relation to the SGA classifications frequently used in previous studies, namely into each of the 4 groups: (1) not SGA using both methods (n¼3631), (2) SGA For fields in which there is no category labelled missing, data were 100% complete. Maternal age was defined as age at recruitment; maternal weight was measured at the time of the dating scan, and maternal height was measured at the time of the 20-week scan. All other maternal characteristics were defined by self-report at the 20-week interview, from examination of the clinical case record, or linkage to the hospital's electronic databases. 1 Deprivation was quantified with the use of the Index of Multiple Deprivation 2007, 15 which is based on census data from the area of the mother's postcode. Sovio & Smith. Customization of birthweight percentile and adverse perinatal outcome. Am J Obstet Gynecol 2018.
FIGURE 1
Proportion of the composite adverse outcome Proportion (%) of the composite adverse outcome in relation to birthweight percentile category.
Cust-FW, customized fetal weight standard; Pop-BW, population birthweight standard (adjusted only for sex and gestational age); Pop-FW, population fetal weight standard (adjusted only for sex and gestational age).
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OBSTETRICS Original Research using the customized method only (SGA-cust; n¼102), (3) SGA using the population birthweight-based standard only (SGA-pop; n¼59), and (4) SGA by both methods (SGA-both; n¼303). This analysis recapitulated the same observation described by many previous studies of increased proportions of pregnancies that are associated with perinatal morbidity and preeclampsia where the infant was SGA-cust (composite outcome 26% vs 12% in the SGA-pop group; P¼.03). However, the SGA-cust group also had much higher rates of preterm birth (16% vs 3%; P¼.02) and maternal obesity (34% vs 2%; P<.001) than the SGA-pop group. Pregnancies classified as SGA-pop were more often nonwhite (25% vs 2%; P<.001), weighed less (56 vs 75 kg; P<.001), were shorter (158 vs 167 cm; P<.001), had a lower body mass index (22 vs 27 kg/m 2 ; P<.001), delivered later (41.3 vs 39.6 wk, P<.001), and had greater proportions of assisted vaginal deliveries (37% vs 22%; P¼.03) than the SGA-cust group. Pregnancies that were classified as SGA-both had a higher smoking prevalence than the other groups combined (12% vs 4%; P<.001), had the lowest birthweight of all the 4 groups (2780 vs 3465 g; P<.001), and were the most likely to have an adverse perinatal outcome (15% vs 6%; P<.001).
We then sought to perform a standardized comparison of the 3 main methods for classifying birthweight percentile as SGA: (1) using a noncustomized birthweight standard (adjusted only for sex and gestational age), (2) using a noncustomized fetal weight standard (adjusted only for sex and gestational age), and (3) using a customized fetal weight standard (adjusted for parity, height, weight, ethnicity, sex, and gestational age). We studied each of these methods in relation to a composite adverse pregnancy outcome: perinatal morbidity and/or maternal preeclampsia. First, we plotted the raw data on the composite adverse outcome in relation to birthweight percentile categories (Figure 1 ). The patterns were broadly similar across the 3 forms of classification.
However, at the lower end of the birthweight percentile range, the customized group had the highest proportion of adverse outcomes; at the upper end of the range, there were greater proportions with adverse outcomes in the other 2 groups.
Given the nonlinear associations between birthweight percentile and the composite adverse outcome, we calculated the predicted risk of the outcome for each woman from a fractional polynomial logistic regression model and analyzed this as a continuous variable using ROC curve analysis (Figure 2 ). There were highly statistically significant associations (P<.0001) between all 3 estimates of birthweight percentile and the composite outcome. However, the area under the ROC curve was virtually identical with all 3 methods, and we observed no statistically significant difference (P¼.07). None of the methods was associated strongly with the composite outcome (the area under the ROC curve was <0.6 for all methods).
We then sought to determine the independent predictive association for each of the approaches in which we could compare like with like and adjust for any associated maternal characteristics. We identified the women in the top 5% and 10% of predicted risk of the composite adverse outcome using the 3 methods (this approach ensured that the same number of women were treated as high risk using the 3 methods).
We then performed univariable and multivariable analysis of the associations with the composite adverse outcome (Table 2 ). All 3 methods demonstrated stronger associations with the top 5% of predicted risk than the top 10%, as expected. For classification of the top 5% of predicted risk as high risk, the methods that used a fetal growth standard showed attenuation after adjustment for gestational age, whereas the birthweight standard did not. Further adjustment for the maternal characteristics, which included body mass index, attenuated the association with the customized standard, but not the other 2 methods. The associations after full adjustment were similar comparing the 3 approaches (each of the odds ratios were within the 95% confidence interval of the other 2 odds ratios).
Finally, we performed linear regression analysis to determine what proportion of the variation in weight could be attributed to maternal characteristics (Table 3) . When the outcome was the estimated fetal weight at 36 weeks gestation, r 2 was 5.5%; when the outcome was birthweight, r 2 was 4.4%.
Comment
We confirmed many previous observations that pregnancies identified as SGA only by a customized growth standard had higher rates of complications than non-SGA pregnancies. 14 Taken at face value, this analysis might be used as further evidence for the beneficial effect of "customizing" birthweight percentile. However, this group was also far more likely to be FIGURE 2 Receiver operating characteristic curve analysis
Receiver operating characteristic curve analysis between the predicted risk and the composite adverse outcome with the use of the customized fetal weight standard (green), the population fetal weight standard (blue), and the population birthweight standard (red). The areas under the receiver operating characteristic curves were 0.56 (95% confidence interval, 0.54e0.59), 0.56 (95% confidence interval, 0.53e0.59) and 0.55 (95% confidence interval, 0.53e0.58), respectively.
Original Research OBSTETRICS ajog.org born preterm and the mothers of these infants to have a higher body mass index. The proportion of preterm birth in this group was almost 4-fold greater than in the non-SGA group, and the proportion of mothers who were obese was almost 3-fold greater. The former observation likely relates to the use of a fetal growth standard because far more preterm infants are classified as SGA when a fetal growth standard is used compared with a birthweight standard. The latter observation is likely explained by the correction of birthweight percentile for the mother's weight. However, it is arguable whether obesity should be regarded, from an evolutionary perspective, as a physiologic determinant of normal fetal growth. Previous studies have shown that classification of infants as SGA on the basis of a customized birthweight percentile is a better predictor of adverse perinatal outcome than a noncustomized birthweight standard. However, the data in Table 1 indicated that these observations should be treated cautiously because they could be due to confounding by preterm birth and obesity.
We then set out to establish whether customization of birthweight percentile resulted in a stronger association with a composite outcome of either preeclampsia or perinatal morbidity, independently of these confounders. First, we observed that all 3 methods of calculating birthweight percentile were associated with an increased risk of adverse outcome. To allow a standardized comparison of the 3 methods, we treated each as a continuous variable and assessed model discrimination using the area under the ROC curve. We performed the analysis in such a way as to capture associations with both reduced and excessive growth. Overall, using this approach, we found no clear evidence that 1 method was superior to the other methods in the identification of adverse pregnancy outcomes. With the use of the top 5% of predicted risk, both methods that used a fetal growth standard demonstrated a weaker association when adjusted for gestational age, whereas adjustment had no effect on the strength of association with the birthweight-based standard. There was a further reduction in the strength of association on adjustment for maternal characteristics with the top 5% of predicted risk based on a customized percentile, but not with the other 2 methods. These findings indicate that the use of a fetal growth standard results in a stronger association with adverse outcome, partly through a tendency to classify more preterm births as SGA. Given that Estimated fetal weight was calculated from the measurements of fetal head, abdomen, and femur with the use of a Hadlock formula as previously described 1, 16 ; it was available for 3802 of the 4095 women who were included in the study population. Maternal weight had a nonlinear association with estimated fetal weight and birthweight, and both linear and quadratic terms were included in the regression models. Sovio & Smith. Customization of birthweight percentile and adverse perinatal outcome. Am J Obstet Gynecol 2018.
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gestational age is one of the major determinants of adverse perinatal outcome, it is self-evident that any classification that enriches for this group will be more associated strongly with morbidity.
The use of customized percentiles has the potential to create a number of problems in the interpretation of relationships between birthweight percentile and adverse outcome. First, neonatologists use birthweight-based charts. Clearly, there is potential for confusion and miscommunication if the obstetric and neonatal teams are using different methods for quantification. Second, the actual equation used in GROW is updated regularly. Hence, comparison of data from 2 different time periods with the use of 2 different iterations of the method will be difficult because it is uncertain whether "like" is being compared with "like." Third, customization based on maternal weight involves making a decision about the threshold of weight when further adjustment is not performed. It is not clear how such a threshold is selected. Fourth, customization may "account" for apparent physiologic determinants of growth that actually lie on the causal pathway and are associated with the risk of adverse outcome. Consistent with this, a recent comparison of noncustomized vs partially customized (accounting for maternal height and parity) birthweight percentile actually showed a weaker association between birthweight percentile and the risk of perinatal death at term after partial customization. 4 These issues may be worth trying to overcome if it is clear that the method works. However, we found no strong evidence to support this and, indeed, identified confounders that may explain the apparent stronger associations in other studies. Finally, although it seems intuitively appealing, if not obvious, that taking maternal characteristics into account would strengthen associations, we observed that maternal characteristics accounted for a relatively modest proportion of the variability (approximately 5%) in both estimated fetal weight and birthweight. Another approach would be to use each fetus as its own control and to determine the appropriateness of growth using the growth velocity; we have provided high-quality evidence from a prospective level 1 study of diagnostic effectiveness to demonstrate that this approach may be the optimal means for the characterization of fetal growth in both SGA and LGA infants. 1, 2 A further approach would be to combine ultrasonic assessment of fetal growth with maternal blood biomarkers of placental dysfunction. n
